Shearman & Sterling represented Evercore ISI as sales agent in connection with the commencement of an at-the-market equity offering program by Quantum-Si Incorporated to offer and sell its Class A common stock having an aggregate offering price of up to $75 million.

Quantum-Si Incorporated is an innovative life sciences company with the mission of transforming single-molecule analysis and democratizing its use by providing researchers and clinicians access to the proteome, the set of proteins expressed within a cell. The company has developed a proprietary universal single-molecule detection platform that it is first applying to proteomics to enable Next-Generation Protein Sequencing, the ability to sequence proteins in a massively parallel fashion (rather than sequentially, one at a time), that can be used for the study of nucleic acids.

The Team